| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―08 |
Analysis of Favipiravir Adverse Drug Reactions during COVID-19 Pandemic: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database |
Yasir Ezalden Noori Alkashab |
| 2 |
[GO] |
2023―Aug―16 |
The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs |
Ghassan Mudher Hashim |
| 3 |
[GO] |
2023―Aug―16 |
Seromucoid and Protein-Bound Hexose as Inflammatory Markers in Sera of COVID-19 Patients |
Jian Lateif Hussein |
| 4 |
[GO] |
2023―Mar―02 |
The most common route of administration used during COVID-19 |
Mena Raid Khalil |
| 5 |
[GO] |
2023―Feb―28 |
Serum Matrix Metalloproteinase-2: A Possible Link between COVID-19 and Periodontitis |
Suhad Jumaa Abd-Alkareem |
| 6 |
[GO] |
2022―Oct―25 |
Analysis of Azithromycin adverse events in COVID-19 Patients reported to Iraqi Pharmacovigilance center in 2020 |
Yasir A. Noori |
| 7 |
[GO] |
2022―Apr―18 |
Two-intervention social distancing strategy to control COVID-19 in Mosul city; A Comparative study |
Muhammad A. Ahmed |
